A novel duplication type of CYP2A6 gene in African-American population
- PMID: 17267622
- DOI: 10.1124/dmd.106.013557
A novel duplication type of CYP2A6 gene in African-American population
Abstract
Human CYP2A6 is responsible for the metabolism of nicotine and its genetic polymorphisms affect smoking behavior and risk of lung cancer. In the present study, we identified a novel type of CYP2A6 gene duplication that is created through an unequal crossover event with the CYP2A7 gene at 5.2 to 5.6 kilobases downstream from the stop codon. The novel duplication type of CYP2A6 was found in African Americans (n = 176) at an allele frequency of 1.7%, but was not found in European-American (n = 187), Korean (n = 209), or Japanese (n = 184) populations. The plasma cotinine/nicotine ratio in subjects possessing the novel CYP2A6 gene duplication with the CYP2A6*1 allele (10.8 +/- 7.0, n = 4) was 1.4-fold higher than that in homozygotes of the wild type (8.0 +/- 5.0, n = 87), although the difference was not statistically significant. The findings in the present study suggested that the novel duplicated CYP2A6 allele, which is specific for African Americans, would increase nicotine metabolism and may affect smoking behavior.
Similar articles
-
In vivo evaluation of coumarin and nicotine as probe drugs to predict the metabolic capacity of CYP2A6 due to genetic polymorphism in Thais.Drug Metab Pharmacokinet. 2006 Dec;21(6):475-84. doi: 10.2133/dmpk.21.475. Drug Metab Pharmacokinet. 2006. PMID: 17220563 Clinical Trial.
-
Genetic polymorphisms in human CYP2A6 gene causing impaired nicotine metabolism.Br J Clin Pharmacol. 2002 Nov;54(5):511-7. doi: 10.1046/j.1365-2125.2002.01667.x. Br J Clin Pharmacol. 2002. PMID: 12445030 Free PMC article.
-
CYP2A6 genotype, phenotype, and the use of nicotine metabolites as biomarkers during ad libitum smoking.Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1812-9. doi: 10.1158/1055-9965.EPI-05-0723. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 17035386
-
Interindividual variability in nicotine metabolism: C-oxidation and glucuronidation.Drug Metab Pharmacokinet. 2005 Aug;20(4):227-35. doi: 10.2133/dmpk.20.227. Drug Metab Pharmacokinet. 2005. PMID: 16141602 Review.
-
Smoking behavior and related cancers: the role of CYP2A6 polymorphisms.Curr Opin Mol Ther. 2007 Dec;9(6):538-44. Curr Opin Mol Ther. 2007. PMID: 18041664 Review.
Cited by
-
Use of a predictive model derived from in vivo endophenotype measurements to demonstrate associations with a complex locus, CYP2A6.Hum Mol Genet. 2012 Jul 1;21(13):3050-62. doi: 10.1093/hmg/dds114. Epub 2012 Mar 26. Hum Mol Genet. 2012. PMID: 22451501 Free PMC article.
-
Parasite-host interaction in malaria: genetic clues and copy number variation.Genome Med. 2009 Sep 2;1(9):82. doi: 10.1186/gm82. Genome Med. 2009. PMID: 19725943 Free PMC article.
-
Role of CYP2A6 in Methimazole Bioactivation and Hepatotoxicity.Chem Res Toxicol. 2021 Dec 20;34(12):2534-2539. doi: 10.1021/acs.chemrestox.1c00300. Epub 2021 Nov 17. Chem Res Toxicol. 2021. PMID: 34788025 Free PMC article.
-
Tobacco Use, Insulin Resistance, and Risk of Type 2 Diabetes: Results from the Multi-Ethnic Study of Atherosclerosis.PLoS One. 2016 Jun 20;11(6):e0157592. doi: 10.1371/journal.pone.0157592. eCollection 2016. PLoS One. 2016. PMID: 27322410 Free PMC article.
-
PharmVar GeneFocus: CYP2A6.Clin Pharmacol Ther. 2024 Oct;116(4):948-962. doi: 10.1002/cpt.3387. Epub 2024 Jul 25. Clin Pharmacol Ther. 2024. PMID: 39051767 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases